JPMorgan Chase & Co. news

   Watch this stock
Showing stories 1 - 10 of about 165   

Articles published

JPM 67.99 -0.92 (-1.34%)
price chart
Shares of J P Morgan Chase & Co (NYSE:JPM) Sees Large Inflow of Net Money Flow ...
J P Morgan Chase & Co (NYSE:JPM) dropped -1.25% or -0.87 points to trade at $68.77 per share. As per the latest trading data available, the net money flow stood at $4.29 million as the shares received $70.74 million in upticks and gave away $66.46 ...
Company Shares of J P Morgan Chase & Co Drops by -0.43% | Insider ...  Insider Trading Report
ConforMIS Receives New Coverage from Analysts at JPMorgan Chase & Co. (CFMS ...
JPMorgan Chase & Co. began coverage on shares of ConforMIS (NASDAQ:CFMS) in a research note issued on Monday, TheFlyOnTheWall.
Earnings: JPMorgan Chase & Co (JPM) Q2 Profit Up 5.2%; Wells Fargo & Co (WFC ...
Earnings season kicks into high gear on Wall Street this week, with five major U.S. banks -- JPMorgan Chase & Co., Wells Fargo & Co.
What To Expect From JPMorgan Chase & Co. (JPM) & Wells Fargo & ...  Bidness ETC
Earnings on Deck: JPMorgan Chase & Co., Wells Fargo & Co, and Bank ...  Schaeffers Research (blog)
Biogen's Overweight Rating Reaffirmed at JPMorgan Chase & Co. (BIIB) - Dakota ...
Biogen logo Biogen (NASDAQ:BIIB)'s stock had its “overweight” rating reiterated by research analysts at JPMorgan Chase & Co. in a report released on Monday, AnalystRatingsNetwork.com reports. They currently have a $414.00 price objective on the ...
Here's what people are saying about Biogen and the biotech sector as a ...  Boston Business Journal (blog)
JPMorgan Chase & Co. Reiterates “Neutral” Rating for Aegerion Pharmaceuticals ...
Aegerion Pharmaceuticals (NASDAQ:AEGR)'s stock had its “neutral” rating restated by equities researchers at JPMorgan Chase & Co. in a research report issued on Monday, MarketBeat reports. A number of other equities research analysts have also ...
Alexion Pharmaceuticals Now Covered by JPMorgan Chase & Co. (ALXN) - Dakota ...
Alexion Pharmaceuticals logo Stock analysts at JPMorgan Chase & Co. initiated coverage on shares of Alexion Pharmaceuticals (NASDAQ:ALXN) in a report issued on Monday, MarketBeat.
JPMorgan Chase & Co. Reiterates Buy Rating for Cogent Communications Holdings ...
Cogent Communications Holdings (NASDAQ:CCOI)'s stock had its “buy” rating restated by equities researchers at JPMorgan Chase & Co. in a research report issued on Monday, ARN reports. Cogent Communications Holdings (NASDAQ:CCOI) traded down ...
Amec Foster Wheeler PLC Given Overweight Rating at JPMorgan Chase & Co. (AMEC ...
Amec Foster Wheeler PLC (LON:AMEC)'s stock had its “overweight” rating restated by JPMorgan Chase & Co. in a research note issued on Monday, StockTargetPrices.
Synaptics, Stock Rating Reaffirmed by JPMorgan Chase & Co. (SYNA) - Dakota ...
Synaptics, (NASDAQ:SYNA)'s stock had its “buy” rating reaffirmed by equities researchers at JPMorgan Chase & Co. in a research report issued on Sunday, MarketBeat Ratings reports. In other Synaptics, news, insider Bretton Sewell sold 2,797 shares of ...
Synaptics, Given "Buy" Rating at JPMorgan Chase & Co. (SYNA ...  WKRB News
Vodafone Group plc Earns Overweight Rating from JPMorgan Chase & Co. (VOD)
Vodafone Group plc logo Vodafone Group plc (LON:VOD)'s stock had its “overweight” rating reissued by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Monday, Market Beat Ratings reports. They currently have a ...
SABMiller plc PT Lowered to GBX 4,050 at JPMorgan Chase & Co. (SAB ...  The Legacy
JPMorgan Chase & Co. Raises Howden Joinery Group Plc Price Target to GBX ...  sleekmoney